Drawing for AVEXXIN

USPTO serial 79013003

AVEXXIN

Reviewed by CopyMark Law Group

Reg. 3112230Status 404
Filing date
Status date
Registration date
Jul 4, 2006
Examiner
EDGE, KATRINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AVEXXIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Scientific, biotechnological and biomedical research in the field of treatment and prevention of inflammatory diseases; development and identification of drugs and drug candidates in the field of treatment and prevention of inflammatory diseases; in vivo and in vitro pre-clinical tests of drug candidates in the field of inflammatory diseases; clinical research in the field of treatment and prevention of inflammatory diseasesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 4, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 12, 2012CHLDCHANGE OF OWNER RECEIVED FROM IB—
Sep 29, 2012DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 7, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 14, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 14, 2007FIMPFINAL DISPOSITION PROCESSED—
Mar 13, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 4, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 22, 2006NPUBNOTICE OF PUBLICATION—
Feb 22, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 17, 2006ALIEASSIGNED TO LIE—
Feb 6, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 6, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 24, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 24, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 14, 2005RFNTREFUSAL PROCESSED BY IB—
Sep 29, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 29, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 28, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2005DOCKASSIGNED TO EXAMINER—
Sep 2, 2005NWAPNEW APPLICATION ENTERED—
Sep 1, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance